concentrations. In contrast, the wild type CHO cells showed a steady increase of [Ca 2+ ] i at higher external Ca 2+ concentrations. The PKC activator PMA (0.3-10 μmol/L) and PKA activator 8-Br-cAMP (10-100 μmol/L) significantly enhanced the reverse mode activity of NCX1.1 and NCX1.5 in CHO cells. NCX1.1 was 2.4-fold more sensitive to PKC activation than NCX1.5, whereas the sensitivity of the two NCX isoforms to PKA activation had no difference. Both PKC-and PKA-enhanced NCX reverse mode activities in CHO cells were suppressed by NCX inhibitor KB-R7943 (30 μmol/L). Conclusion: Both NCX1.1 and NCX1.5 are functional in regulating and maintaining stable [Ca 2+ ] i in CHO cells and differentially regulated by PKA and PKC. The two NCX isoforms might be useful drug targets for heart and brain protection.
Introduction
The Na + /Ca 2+ exchanger (NCX) is an ion transporter that is expressed in the plasma membrane of almost all cell types. It plays a pivotal role in the regulation of homeostasis of intracellular Ca 2+ concentration ([Ca 2+ ] i ) in cardiac, neuronal and kidney cells [1] [2] [3] . So far, three mammalian isoforms of the Na + / Ca 2+ exchanger have been cloned [4] [5] [6] . The isoforms NCX1, NCX2 and NCX3 are products of distinct genes. NCX1 is ubiquitously expressed in many tissues, including heart, brain and kidney, while NCX2 and NCX3 are mainly found in the brain and skeletal muscle [7] . The transcripts coding for NCX1 show unique tissue-specific expression patterns. For instance, splicing variant NCX1.1 (containing exons ACDEF) is dominant in the heart, while NCX1.5 (containing exons ADF) is the predominant splicing product expressed in the brain [8] . To date, the interactions between NCX1 and various extracellular and intracellular factors such as Na + and Ca 2+ , pH, adenosine triphosphate (ATP), phosphatidic acid (PA), phosphatidylinositol 4,5-bisphosphate (PIP 2 ), protein kinase A (PKA) and protein kinase C (PKC) have been extensively characterized [9] . Although the activity of cardiac NCX1.1 is known to be regulated by PKC-mediated signaling [10] , the regulation of NCX1.1 activity by the PKA pathway is not fully defined [11] . In addition, studies testing the regulation of NCX1.5 by PKA and PKC were reported rarely. Some authors reported that a phosphorylation step could accelerate the transporting function of the Na + /Ca 2+ exchanger [12] [13] [14] , but others failed to observe the same effect [15, 16] .
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Our previous work demonstrated that NCX1 plays an important role in transient focal cerebral ischemia [17] . We also reported that intracellular ATP depletion and acidification synergistically impaired Ca 2+ extrusion via forward mode Na + / Ca 2+ exchange in ventricular myocytes isolated from guinea pig [18] . These results suggest that NCX1 plays a critical role in the pathophysiology of transient focal cerebral ischemia and cardiac ischemia, and it is due to the calcium overload induced by reverse mode Na + /Ca 2+ exchange. Attempts to clarify the participation of the Na + /Ca 2+ exchanger in physiological and pathological processes have been made since this antiporter was found in 1969 [19] , but these studies have been hampered by the lack of compounds that can selectively block this carrier. In 1996, Iwamoto et al reported that KB-R7943 could selectively inhibit the NCX reverse activity [10] , and subsequently, others found that KB-R7943 was also an effective inhibitor of nicotinic acetylcholine receptors (nAChRs), the N-methyl-D-aspartic acid (NMDA) receptor, ryanodine receptors (RyRs) and transient receptor potential (TRP) channels [20] [21] [22] [23] . Our laboratory found that KB-R7943 inhibited both directions of the exchange current with an almost equal potency [24] . Currently, the exact role of NCX1 in physiological and pathophysiological conditions remains to be studied. The reverse mode activity of NCX may play an important role in enhancing intracellular Ca 2+ levels especially under pathophysiological conditions. In this study, we expressed two isoforms of NCX1 (NCX1.1 and NCX1.5, mainly expressed in the heart and brain, respectively) in CHO cells and investigated the modulation of their reverse mode activity by PKC and PKA.
Materials and methods
Cell culture and transfection CHO-K1 cells (ATCC, Manassas, VA, USA) were cultured in F12-K media (Gibco, Carlsbad, CA, USA) supplemented with 10% fetal bovine serum. NCX1 plasmids were generously provided by Dr Jonathan LYTTON (University of Calgary, Calgary, Alberto, Canada). Using Lipofectamine (Invitrogen, Carlsbad, CA, USA) transfection reagent, CHO-K1 cells were transfected with pcDNA3.1 (+) plasmid carrying rat cDNA of cardiac NCX1.1 and brain NCX1.5. To select the transfected cells, G418 (Sigma-Aldrich, St Louis, MO, USA) was applied to the transfected and non-transfected cells in graded concentrations. The effective concentration was determined to be the concentration that inhibited 100% of the non-transfected cells. Cells stably expressing high levels of NCX proteins were selected by a Ca 2+ killing procedure [25] . Single-cell clones that expressed similar levels of NCX1.1 and NCX1.5 proteins were chosen for the study.
Preparation of membrane proteins and Western blot analysis
Stably transfected CHO-K1 cells were collected and suspended in lysing buffer containing 10 mmol/L Tris-HCl, 2 mmol/L phenylmethylsulfonyl fluoride, 2 mmol/L EDTA and 1 mmol/L dithiothreitol and then subjected to three freeze-thaw cycles. The particulate fraction was gathered by centrifugation at 11 000×g for 30 min at 4 °C and resuspended in 5 mmol/L Tris-HCl at pH 8.0 and 10% sucrose. The protein concentration was determined by the Bradford method. The membrane protein samples (25 μg) were separated on 8% SDS-PAGE gels and transferred to PVDF membranes. The membrane was incubated overnight with a rabbit polyclonal antibody against NCX1 (Chemicon, Temecula, CA, USA) at a 1:400 dilution. After extensive washing, the membranes were incubated with anti-rabbit horseradish peroxidase-conjugated secondary antibodies (Santa Cruz Biotechnology, Santa Cruz, CA, USA), and the blot was rinsed and visualized using ECL (Fujifilm, Tokyo, Japan) and quantified using Kodak 1D software. containing 3 μmol/L fura 2-AM and 1% bovine serum albumin for 1 h at room temperature. After loading, the cells were washed three times with the bath buffer and used for measurements. A Lamda DG4 system (Sutter Instrument Co, Novato, CA, USA), under the control of Metafluor software (Molecular Devices, Sunnyvale, CA, USA), was used for Fura-2 excitation. The ratio within each cell was computed from images obtained at excitation wavelengths 340 and 380 nm and by subtracting the background fluorescence at each wavelength; emission was monitored at 510 nm. Time-lapse recording initially captured the images at 1-s intervals. To minimize cell photobleaching throughout the experiment, the intervals were increased to 3 s. Data presented were acquired at 3-s intervals. The experiment was repeated on multiple coverslips. Phorbol 12-myristate 13-acetate (PMA), 8-bromoadenosine 3',5'-cyclic monophosphate (8-Br-cAMP) and other chemical reagents were purchased from Sigma unless otherwise indicated.
NCX reverse mode activity Cells were incubated in bath buffer containing 0.1 mmol/L ouabain to increase the [Na + ] i . To elicit reverse mode NCX activity, the bath buffer was switched to Na ] i plotted against time. All the results are presented as the cytosolic Ca 2+ concentration. The fluorescent signal was calibrated in vivo at the end of each experiment using the method described by Grynkiewicz et al [26] . The dissociation constant of Fura-2 for Ca 2+ was considered to be 224 nmol/L. The maximum ratio (R max ) was obtained by permeabilizing the cells with a Ca 2+ ionophore, ionomycin (10 μmol/L), in the presence of 1.5 mmol/L extracellular Ca 2+ . The minimum ratio (R min ) was subsequently obtained by the exposure of cells to a Ca 2+ -free solution (containing 10 mmol/L EGTA and 10 μmol/L ionomycin). 
Electrophysiological recordings
The NCX currents were recorded from whole-cell patch configuration by the patch-clamp technique using EPC10 amplifiers (HEKA Electronics, Lambrecht, Germany) at room temperature (22-24 °C). Currents were elicited by an ascending ramp pulse depolarized immediately from a holding potential of 0 mV to 100 mV and then hyperpolarized to -100 mV at 0. 
Statistical analysis
The data are presented as mean±SEM. Statistical significance was evaluated by Student's t-test or a one-way analysis of variance followed by Dunnett's test using SPSS software.
P<0.05 was considered to be statistically significant.
Results
Expression and function of NCX1.1 and NCX1.5 in transfected CHO cells The expression levels of NCX1 isoforms were analyzed to verify the transfection efficacy in CHO cells. As shown in Figure 1A and 1B, Western blot analysis of NCX-transfected CHO cells showed two proteins with molecular masses of 120 kDa and 160 kDa that were not present in the wide-type CHO cells. The 120 kDa and 160 kDa proteins correspond to the mature NCX1 protein and the intra-molecular disulfide protein [27] . NCX1.1 and NCX1. 5 Figure 1C and 1D) .
We examined the effects of KB-R7943, a potent NCX inhibitor, on the NCX current induced by a ramp pulse in the two transfectants. We observed that KB-R7943 inhibited the NCX current in a concentration-dependent manner at +80 mV. No significant differences were observed in the KB-R7943 inhibition of the NCX current between the two NCX1 isoforms (Figure 2A and 2B) . , the transient increase in Ca 2+ levels was higher in NCX1.1 and NCX1.5 cell lines than that in WT cells ( Figure 3D-3F and 3H) . Meanwhile, the Ca 2+ level plateaus were lower in the transfected cell lines than that in WT cells ( Figure 3G and 3H) Figure 4A and 4C) , and a significant increase was observed from 0.3 μmol/L PMA to a maximum level at 3 μmol/L. The NCX1.5 transfectant was less sensitive to PKC activation compared to cells transfected with NCX1.1. A significant increase of [Ca 2+ ] i was observed at 10 μmol/L PMA for NCX1.5. The concentration of PMA for the maximal [Ca 2+ ] i effect was 2.4-fold higher in the NCX1.5 cell line than that in NCX1.1 cells (Figure 4B and 4D ] i rise was dependent on external calcium. 2+ ] i in NCX1 transfectants at reverse mode To determine the role of PKA phosphorylation in modulating NCX1 activity, we examined the effects of PKA activator 8-BrcAMP on NCX reverse mode. When 8-Br-cAMP was added during perfusion, the Ca 2+ influx was increased by about 3-fold in cell lines transfected with NCX1.1 or NCX1.5 (Figure 5) . However, this result was different when compared to that of PKC activation; PKA activator 8-Br-cAMP caused an intracellular calcium oscillation in NCX-transfected cells even at the relatively lower concentration of 10 μmol/L. The representative traces of [Ca 2+ ] i oscillations in response to 8-Br-cAMP treatment are shown in Figure 5A and 5B. To further determine whether the intracellular Ca 2+ enhanced by 8-Br-cAMP was mediated by NCX, the NCX1 subtype cell lines were preincubated with 30 μmol/L KB-R7943 for 20 min before PKA activation. KB-R7943 significantly reduced the Ca 2+ uptake induced by 8-Br-cAMP (P<0.01, Figure 5C and 5D). However, the Ca 2+ oscillation was not significantly inhibited. The Ca ] i was mainly due to the extracellular solution.
8-Br-cAMP increased [Ca

Discussion
The reverse mode-mediated increase of [Ca 2+ ] i exhibited two phases: a transient increase and a steady-state level when -activated cationic channel that is constitutively expressed in CHO cells [28] . A similar phenomenon was observed by Chernysh [29] . However, the [Ca 2+ ] i increase was more striking in the NCX transfected cells than in the wide-type cells because of the reverse mode activity [30] . To date, the cardiac exchanger NCX1.1 has been extensively studied with respect to structure, function and regula tion [31, 32] . However, the isoform NCX1.5, expressed mainly in neuronal cells, is rarely reported. Our present results indicate that NCX1.1 and NCX1.5 exhibit similar responses to PKA activation with 8-Br-cAMP and a rapid rise and decline of intracellular Ca 2+ , which is a specific property of NCX reverse mode activity. Furthermore, we found that 8-Br-cAMP repeatedly induced an intracellular Ca 2+ increase after immediate exposure to the cells, ie, the oscillation of Ca 2+ . This 8-Br-cAMP- [33, 34] . Interestingly, the behaviors of intracellular Ca 2+ activated by PKA were different from those by PKC activation. This result indicates that the targets of phosphorylation by PKC and PKA for modulation of Ca 2+ release might be different.
In the present study, we demonstrated that NCX1.1 was more sensitive to PKC activation with PMA. At 0.3 μmol/L of PMA, the Ca 2+ peak level was enhanced by two-fold and at the 3 μmol/L of PMA, the activity of NCX1.1 reverse mode reached its maximum. NCX1.5 was not sensitive to PMA activation. The half maximal activation and the maximal activation were about 3 and 10 μmol/L, respectively; they were 2+ increase observed in our study is in accordance with previous reports [35] , and evidence for NCX1.1 phosphorylation by PKC has also been reported [35] . Further studies performed in cardiac myocytes [6, 7, 25] revealed that cardiac NCX (mainly 1.1 isoform) might be regulated by not only PKC but also PKA-mediated phosphorylation at the intracellular loop of the NCX [10, [36] [37] [38] [39] . The regulation of PKA and PKC on NCX1.5 was not reported previously. Our results demonstrate that PKA and PKC activation could enhance the activities of reverse mode NCX1.5.
In addition, we also demonstrated that NCX1.5 showed a lower sensitivity to PKC and almost same sensitivity to PKA as NCX1.1.
Because of the broad tissue distribution of NCX1 isoforms and the absence of specific blockers for NCX1.1 and NCX1.5, it is difficult to investigate the regulation of NCX isoforms in native tissues. Our study demonstrates that NCX1.1 and NCX1.5 cell lines could be used to study some functions of NCX isoforms in heart tissue and in neurons, especially to investigate the regulations of the intracellular Ca 2+ level by PKA and PKC through NCX1.1 and NCX1.5 (in heart and in neurons, respectively) under pathophysiological conditions. The data in our study showed that in NCX1.5 cell lines, the transient increase of intracellular Ca 2+ induced by PKC was lower than that in NCX1.1, which might indicate the functional requirement for neuronal cells. In addition, because PKA and PKC are activated by various G protein-coupled receptors (GPCRs), both cell lines can be used as tools for studying the effects of certain GPCRs on intracellular Ca 2+ through NCX in heart and brain tissues in the future.
These results suggest that NCX plays an important role in mediating a transient increase in Ca 2+ levels and that NCX can prevent calcium overload under physiological or pathophysiological conditions. Cell lines stably transfected with NCX1 isoforms are therefore useful for further exploring the phosphorylation mechanisms involved in the regulation of NCX activity by protein kinases. NCX1.1 and NCX1.5 could be also validated as potential drug targets for protection of heart or brain injury from Ca 2+ overload. 
